Torsade de pointes: the clinical considerations

Area of Science:

• Cardiology
• Clinical Electrophysiology
• Pharmacology

Background:

• Torsade de pointes (TdP) is a specific polymorphic ventricular tachycardia linked to a prolonged QT interval on an electrocardiogram.
• Prolonged QT interval arises from congenital genetic mutations affecting ion channels or acquired factors, frequently drug-induced.
• Certain antiarrhythmic drugs (e.g., quinidine, sotalol) and many non-antiarrhythmic medications can prolong the QT interval and precipitate TdP.

Purpose of the Study:

• To elucidate the pathophysiology of Torsade de pointes.
• To differentiate between congenital and acquired Long QT Syndrome.
• To outline clinical considerations and management strategies for Torsade de pointes.

Main Methods:

• Review of existing literature on Torsade de pointes.
• Analysis of drug-induced QT prolongation mechanisms.
• Clinical case reviews and management guideline synthesis.

Main Results:

• Identified genetic mutations and drug-induced channelopathies as primary causes of prolonged QT interval.
• Highlighted the critical role of potassium channel blockade by various medications in acquired Long QT Syndrome.
• Emphasized that congenital and acquired forms of Long QT Syndrome can coexist.

Conclusions:

• Distinguishing between congenital and acquired Long QT Syndrome is vital, as acquired forms may be reversible.
• Discontinuation of offending drugs or correction of underlying conditions can manage acquired Torsade de pointes.
• Comprehensive understanding of TdP etiology and management is essential for clinical practice.